Login / Signup

Effect of the response to preoperative treatment for hepatorenal syndrome on the outcome of recipients of living-donor liver transplantation.

Ryugen TakahashiNobuhisa AkamatsuAkiko NakazawaRihito NagataAkihiko IchidaYoshikuni KawaguchiTakeaki IshizawaJunichi KanekoJunichi AritaKiyoshi Hasegawa
Published in: Journal of hepato-biliary-pancreatic sciences (2022)
Living-donor liver transplantation is safe and effective for patients with HRS, and CKD progression could be reduced among those with HRS who responded to renal restoration treatment.
Keyphrases
  • chronic kidney disease